Aurubis (ETR:NDA) has been given a €77.00 ($95.06) price target by stock analysts at Independent Research in a report issued on Wednesday. The brokerage currently has a “neutral” rating on the stock. Independent Research’s price target suggests a potential upside of 2.53% from the stock’s previous close.
A number of other research firms have also issued reports on NDA. Deutsche Bank set a €75.00 ($92.59) target price on Aurubis and gave the company a “neutral” rating in a report on Monday, January 22nd. Macquarie set a €66.00 ($81.48) target price on Aurubis and gave the company a “sell” rating in a report on Wednesday, January 24th. Warburg Research set a €90.00 ($111.11) price objective on Aurubis and gave the stock a “buy” rating in a report on Wednesday, January 17th. DZ Bank reissued a “neutral” rating on shares of Aurubis in a report on Tuesday, January 16th. Finally, Morgan Stanley set a €64.00 ($79.01) price objective on Aurubis and gave the stock a “sell” rating in a report on Thursday, January 11th. Six equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of €73.48 ($90.71).
Shares of Aurubis (ETR:NDA) opened at €75.10 ($92.72) on Wednesday. The stock has a market capitalization of $3,320.00 and a P/E ratio of 9.62. Aurubis has a fifty-two week low of €51.54 ($63.63) and a fifty-two week high of €86.80 ($107.16).
Aurubis Company Profile
Aurubis AG engages in the copper concentrate processing, metal recycling, and copper product fabrication activities in Europe, Asia, the United States, and internationally. It operates in two segments, Primary Copper and Copper Products. The company procures and processes copper concentrates; produces and markets exchange-traded copper cathodes; and produces and markets sulfuric acid, iron silicate, precious metals, and specialty products.
Receive News & Ratings for Aurubis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurubis and related companies with MarketBeat.com's FREE daily email newsletter.